Claris Lifesciences’ promoter seeks delisting of shares from stock exchange

04 Dec 2017 Evaluate

Claris Lifesciences has received a letter from the promoter Athanas Enterprise to consider delisting of shares of the pharma company from the stock exchange. The promoter/promoter group currently holds 50.13% of the share capital of the company.

The promoter along with the promoter/promoter group of the company has expressed its intention to make a voluntary delisting offer, either by itself or along with one or more subsidiaries to acquire 2,72,11,801 equity shares of Rs 10 each representing 49.87% of the paid up share capital of the company held by the public shareholders and accordingly delist the equity shares of the company from the exchange.

Further, the promoter has requested the board of directors of the company to consider and approve the delisting proposal in accordance with the regulations.

Claris Lifesciences is engaged in manufacturing of drugs and pharmaceutical products. The Company manufactures and markets products across multiple delivery systems, markets and therapeutic segments, including anesthesia and analgesics, blood products, anti-invective's, critical care, and nephrology.


Peers
Company Name CMP
Adani Enterprises 2990.45
Redington 218.20
Amrapali Industries 14.53
Rashi Peripheral 343.65
Compuage Infocom 4.82
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.